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1. Introduction 
An endogenous peptide with opioid agonist activity, 
termed enkephalin, has been isolated from the porcine 
brain [ 1 ] , and more recently the primary structure of 
this pentapeptide has been elucidated: H-Tyr-Gly- 
Gly-Phe-Fe: -OH [2]. Hughes et al. [2] pointed out 
that the complete sequence of the major form of 
enkephalin, Met-enkephalin, is contained in the 
primary structure of pituitary /3-lipotropin between 
amino acid residues 61-65 [3-51. This sequence 
overlap raises the possibility that /I-lipotropin may be 
the biological precursor of enkephalin and/or other 
pituitary peptides with morphine-like activity. As an 
approach to this question the possible microhetero- 
geneity of porcine /3-lipotropin at sequence position 
65, and the opiate agonist activities of /3-lipotropin 
and some fragments of the hormone obtained by 
enzymic cleavages were investigated. The results of 
these studies are reported in this paper. 
2. Experimental 
2.1. Preparation and characterization of P_lipotropin 
and P_lipo tropin fragments 
Porcine /I-lipotropin was isolated by a procedure 
described previously [6]. Prior to biological measure- 
Abbreviations: LPH, lipotropic hormone (lipotropin); Boc, 
t-Butyloxycarbonyl; EEDQ, ethyloxycarbonyl-2-ethyloxy- 
1,2-dihydroquinoline; EtOAc, ethyl acetate. 
*Rf values were obtained in thin-layer chromatography using 
an ethyl acetate-pyridine-acetic acid-water (60:20:6:11) 
system. 
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ments our preparation was subjected to chromatography 
on a Bio-Gel P-6 column in 10% acetic aoid. Tryptic 
digestion was carried out in 0.05 M NH4HC0s, pH 8.0 
with an enzyme to peptide ratio of 1: 50 (w/w) at 
37°C for 2 h. Isolation of the tryptic fragment from 
residues 61-69 of the /3-lipotropin sequence (LPH- 
(61-69)peptide) was performed by preparative high 
voltage paper electrophoresis at pH 6.5 and subsequently 
at pH 2.0 [4]. The amino acid composition of a 
complete aminopeptidase M hydrolysate from LPH- 
(61-69)peptide was as follows. LYsI.~, MeSO,, , 
mrl.0, Sero.9, G1q.0, Gly1.9, Met 0.8, Tyro.9, PheI 0. 
This composition is in agreement with that derived ’ 
from the sequence proposed for this region of the 
lipotropin molecule: Tyr-Gly-Gly-Phe-Met-Thr- 
Ser-Glu-Lys [3-51. It is worth mentioning that no 
trace of leucine could be detected in LPH-(61-69) 
peptide. 
Specific cleavage of the Lys-Ser bond at sequence 
positions 69-70 of fl-lipotropin by a homogenate of 
fresh pituitary glands, and the isolation of the large 
NH2-terminal fragment (LPH-(l-69)peptide) is 
published elsewhere. 
2.2. Synthesis of Met-enkephalin 
Boc-Tyr-Gly-Gly and Phe-Met-OMe were 
condensed by EEDQ to obtain the protected penta- 
peptide ester, I. Boc group of I was removed by 
EtOAc/HCl to yield Met-enkephalin methyl ester 
(m.p. 140-143°C with decomposition, R, 0.52-0.57*). 
Saponification of I led to Boc-Tyr-Gly-Gly-Phe-Met, 
II (crystallized from ethyl acetate, m.p. 149-151°C 
with decomposition, Rf 0.59-0.64). 
Deblocking of II by EtOAc/HCl gave Met-enkepha- 
lin hydrochloride (m.p. 139%142°C R, 0.29-0.34, 
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bl D 2o t 18”, c = 1, in 1 M acetic acid). Amino acid 
analysis of Met-enkephalin after digestion with amino- 
peptidase M gave the following result: G1y2,u, MetuB, 
Tyrl.0, Phel.0. 
2 min 
2.3. Bioassay 
The presence or absence of opioid agonist activity 
as well as the relative agonist potencies of different 
peptide fragments were determined on longitudinal 
muscle strip of guinea-pig ileum. It has been shown [7] 
that opiate receptors of the above muscle preparation, 
in their drug-binding properties, show close similarities 
to those of the opiate receptors in the central nervous 
system which may be involved in analgesic action of 
morphine-like drugs. 
1 L 
1.4 x 1O-7 M 
Normorphine 
1.6 x 10-6Mfi - I ;PH 
_- _ , ! -: ;_;_: 
The longitudinal muscle strip of guinea-pig ileum 
was prepared as described in Paton and Vizi [8]. The 
experiments were carried out in Krebs’ solution bubbled 
with 5% CO, in oxygen at 37°C. The composition of 
the Krebs solution was as follows (in mM): NaCl 118; 
NaHCO, 25; glucose 11.5; KC1 4.7; KH2P04 1.2; 
CaCl, 2.5 and MgSO, 1.2. Field electrical stimulation 
[8] was used by means of platimrm wire or ring elec- 
trodes. The parameters of the stimulation applied were 
following: supramaximal(l.5 times the maximal 
voltage) rectangular stimuli of 1 msec duration delivered 
at a rate of 0.1 Hz. For the simultaneous measure- 
ment of agonist and antagonist activity, the method 
of Kosterlitz and Watt [9] was used. 
1 1 
1.4 x 10-7M 
Normorohine 
I 10m7 M Naloxone 
8 x 1O-7 M/j - LPH(T 
Fig.1. The depressant effects of normorphine, plipotropin 
@LPH) and a tryptic digest of p-lipotropin (p-LPH (Tr)) on 
the electrically induced contractions of longitudinal muscle 
strip from guinea-pig ileum. 
3. Results Table 1 
Relative agonist potencies of the peptides studied 
Highly purified /3-lipotropin and LPH-( 1-69)- 
peptide proved to be inactive as opioid agonist in 
longitudinal muscle strip of guinea-pig ileum at 
concentrations as high as 1.6 X 1 0e6 M and 8 X 10e7 
M, respectively. However, tryptic digestion of both 
polypeptides led to the appearance of agonist activity 
as it is demonstrated for /3-lipotropin in fig. 1. The 
agonist activities of the tryptic digests were found to 
be 2-8 times less than that of normorphine or Met- 
enkephalin. 
Compound Agonist potency ratios 
(relative to normorphine) 
Normorphine 
p-lipotropin 
LPH-(I-69)peptide 
LPH-(61-69)-peptideC 
Met-enkephalinc 
1 (n = 8) 
16 
0.4 * 0.05 (n = 4)d 
0.9 f 0.2 (n = 4)d 
Considering that the Met-enkephalin sequence is 
contained between residues 61-65 of the /3-lipotropin 
structure [2] , theoretically the LPH-(61-69)peptide 
could account for the morphine-like activity of the 
tryptic hydrolysates. Indeed, highly purified LPH- 
a Highest dose tested: 1.6 X 10m6 M. 
b Highest dose tested: 8.0 X 10m7 M. 
’ Concentration of the peptides was determined spectrophoto- 
d 
metrically. 
Mean + SEM values are listed, the number of experiments are 
in parentheses. For the difference between LPH-(61-69)- 
peptide and normorphine p < 0.02. The difference between 
Met-enkephalin and normorphine is not significant. 
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. Fig.2. Dose-response curves for normorphine (o), synthetic 
Met-enkephalin (X) and LPH-(61-69)-peptide (0). 
(61-69)peptide was found to possess an agonist 
potency 2.5 times weaker than that of normorphine. 
The relative agonist potencies of the peptides studied 
are listed in table 1. The dose-response curves for the 
active peptides, Met-enkephalin and LPH-(61-69) 
peptide, were parallel to that of normorphine (fig.2). 
The potency ratio obtained for normorphine: Met- 
enkephalin shows fair agreement with the results of 
Hughes et al. [2]. 
The inhibitory effect of peptides, tested at a 
depression of 70-90% could be completely antagoniz- 
ed by 1 0e7 M naloxone. 
4. Discussion 
The above data give some useful information on 
the structure-activity relationship in enkephalin. The 
fact that LPH-(61-69)peptide shows comparable 
opiate agonist potency with that of enkephalin in 
guinea-pig ileum suggests that the free carboxyl group 
of methionine is not necessary for the morphine-like 
action. To support this assumption synthetic Met- 
enkephalin methyl ester gave identical biological 
response with that of Met-enkephalin as tested in a 
preliminary experiment. The COOH-terminal tetra- 
peptide portion of LPH-(61-69)-peptide however, 
seems to moderate the biological potency of 
the peptide as compared to that of Met-enkephalin 
(fig.2, table 1). As to the lack of significant opioid 
properties of intact fl-lipotropin and LPH-(l-69) 
peptide, it may be speculated that the large NH,- 
terminal portion of these polypeptides sterically 
hinders the opiate receptor-active site interaction. 
The fact that only methionine was found at 
sequence position 65 of porcine fi-lipotropin is 
inconsistent with the assumption that pituitary 
/3-lipotropin may be the sole biological precursor 
of brain enkephalin. Porcine enkephalin has been 
shown to contain a mixture of methionine and 
leucine at the corresponding sequence position [2]. 
On the other hand, S-lipotropin may be one of 
the sources of pituitary substances with opiate 
agonist activity*. Tryptic digestion of /3-lipotropin 
provides a reasonable model for the release of such a 
peptide. In fact, pituitary has been known to be rich 
in trypsin-like enzymes [ 111. Whether or not such a 
cleavage mechanism really operates and has a physio- 
logical role in the pituitary, are open questions. It is 
tempting to speculate however, that LPH-(l-69) 
peptide obtained by incubation of /3-lipotropin with 
pituitary homogenate, might be a common inter- 
mediary precursor for both /3-melanotropin and an 
enkephalin-like peptide. 
In preliminary experiments the in vivo analgesic 
activity of some of the above peptides have been 
investigated. The peptides were administered 
intracerebroventricularly, and the pain treshold was 
measured by the ‘tail-flick’ method in rats [ 121. 
Morphine in a dose of 20 1.18 per animal caused a 
strong analgesic effect, whereas Met-enkephalin and 
the tryptic digest of porcine /3-lipotropin in equimolar 
dose were found to be practically inactive. Surprisingly, 
intact @-lipotropin in equimolar dose showed a 
considerable efficacy. To our present knowledge this 
is the first observation on the in vivo analgesic activity 
of a natural polypeptide. 
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